Company
United StatesPublic company, NYSE: CLColgate Palmolive Company (NYSE: CL), Morristown, NJ – FDA Inspections
Inspection records and compliance data for Colgate Palmolive Company in Morristown, New Jersey. 3 FDA inspections on record, last inspected March 17, 2016. Publicly traded as NYSE: CL.
Company Profile
This profile covers Colgate Palmolive Company based in Morristown, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected April 7, 2011. Last inspected March 17, 2016.
Most cited issue areas
- Complaint Handling Procedure1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 17, 2016 | NAI | Human Drugs · Drug Quality Assurance | 964554 |
| September 9, 2013 | NAI | Human Drugs · Drug Quality Assurance | 847230 |
| April 7, 2011 | VAI | Human Drugs · Drug Quality Assurance | 728648 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Colgate Palmolive Company
Stock ticker
CL
Exchange
NYSE
Share price
$98.71
Market cap
$78.5B
Price as of
November 6, 2026
FEI Number
2211157
Address
191 E Hanover Ave, Morristown, New Jersey 07960, United States
Country
United States
ID: ae3e40db-bc50-434f-84ea-b3a49b28f38e